Risk Factors for Ligamentum Flavum Hypertrophy in Lumbar Spinal Stenosis Patients
NCT ID: NCT03057353
Last Updated: 2017-02-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
104 participants
OBSERVATIONAL
2012-05-31
2017-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Posterior Ligament Complex Assessment Without Magnetic Resonance Image in Thoracolumbar Fractures
NCT02950532
Is Postoperative Bracing Necessary After Spine Surgery for Degenerative Conditions
NCT03560401
Association Between Lumbar Muscle Atrophy, Sagittal Pelvic Alignment and Stenosis Grade in Patients With Degenerative Lumbar Spinal Stenosis
NCT04444739
Lumbar Intervertebral Disc Herniation
NCT02110186
Flexion-Extension Radiograph Imaging Protocol Reliability Study
NCT05633550
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Many previous studies concern pedicle morphology, lumbar ligamentum flavum, lamina and articular process, and important reference data are listed in Table 1. Safak et al. verified that ligamenta flavum thickness was not associated with sex; ligamenta flavum was remarkably thicker on the left side of segments L4/5 and L5/S1 than that on the right side; ligamenta flavum thickness was not positively correlated with age. Few studies address whether ligamenta flavum thickness was associated with nationality, sex and obesity.
Data collection, management, analysis and open-access
1. Written and electronic data were collected. The electronic data were stored in a specialized computer, and locked by the data manager. The written data were stored and locked in a reference room. The key was kept by the data manager and laboratory manager.
2. The locked database was not altered and was preserved, along with the original records. The database was statistically analyzed by a professional statistician.
3. Prior to any analysis of the data, the analysis plan outlined in this section would be reviewed, and detailed statistical analysis plans would be prepared and approved. All data regarding this trial were preserved by the Sixth Affiliated Hospital, Xinjiang Medical University, China.
4. Anonymized trial data would be published at www.figshare.com.
Statistical analysis
1. All data were analyzed using SPSS 21.0 software (IBM, Armonk, NY, USA).
2. All measurement data were normally distributed and expressed as mean ± standard deviation.
3. Ligamentum flavum thickness was compared among groups using two-sample t-test or one-way analysis of variance. Paired comparison between groups was conducted using Student-Newman-Keuls test. Correlation of nationality, sex, height, age and weight with ligamentum flavum thickness was analyzed using Pearson's correlation coefficient. Risk factors for ligamentum flavum hypertrophy were analyzed using multiple linear regression analysis. Odd ratio and 95% confidence interval were calculated.
4. The significance level was α = 0.05.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
lumbar CT imaging
Collecting lumbar CT imaging data of 104 patients with lumbar spinal stenosis to observed the incidence of ligamentum flavum hypertrophy of patients with different nationalities, sexes, heights, ages, and weights and explored risk factors affecting ligamentum flavum hypertrophy.
lumbar CT imaging
Collecting lumbar CT imaging data of 104 patients with lumbar spinal stenosis to observed the incidence of ligamentum flavum hypertrophy of patients with different nationalities, sexes, heights, ages, and weights and explored risk factors affecting ligamentum flavum hypertrophy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
lumbar CT imaging
Collecting lumbar CT imaging data of 104 patients with lumbar spinal stenosis to observed the incidence of ligamentum flavum hypertrophy of patients with different nationalities, sexes, heights, ages, and weights and explored risk factors affecting ligamentum flavum hypertrophy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Complained of low back pain
* Age between 45 and 80 years old
* Irrespective of sex
* Signed informed consent
Exclusion Criteria
* Spinal tumor
* Spinal infection
* Congenital or acquired spine deformity
* Pulmonary tuberculosis
* Severe systemic disease such as malignant tumor
* Cannot cope with the doctor due to mental illness or other causes
45 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sixth Affiliated Hospital of Xinjiang Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gang Zhou
Attending Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gang Zhou, Master
Role: PRINCIPAL_INVESTIGATOR
Sixth Affiliated Hospital of Xinjiang Medical University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SixthAHXinjiang_01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.